Results 31 to 40 of about 15,421,997 (282)

Understanding Stimulant Use and Use Disorders in a New Era

Medical Clinics of North America, 2022
Extending from the triple wave epidemic of opioid-related overdose deaths, a fourth wave of high mortality involving methamphetamine and cocaine use has been gathering force. This article provides a review of the published literature on stimulants including epidemiology, pharmacology, neurobiology, medical and psychiatric consequences, withdrawal ...
Ciccarone, Daniel, Shoptaw, Steve
openaire   +4 more sources

ADHD, Conduct Disorder, Substance Use Disorder, and Nonprescription Stimulant Use [PDF]

Journal of Attention Disorders, 2014
Objective: To assess whether the relationship of an ADHD diagnosis by adolescence to nonprescription stimulant use in adulthood is direct or indirect, via Conduct Disorder (CD) and/or Substance Use Disorder (SUD). Method: Data were obtained from multiple waves of interviews and questionnaires completed by 551 community-based participants when they were
Judith S, Brook, Elinor B, Balka, Chenshu, Zhang, David W, Brook   +3 more
openaire   +2 more sources

Stimulant Use Disorder (SUD): A Clinical Review

, 2023
Stimulant Use Disorder (SUD) is primarily treated with nonpharmacological and pharmacological treatment options. Evidence has shown that contingency management (CM) is an important non-pharmacological treatment option that can be utilized in the ...
Polewski, Mike
core   +1 more source

Stimulant treatment for attention-deficit hyperactivity disorder and risk of developing substance use disorder [PDF]

, 2013
BackgroundAttention-deficit hyperactivity disorder (ADHD) is linked to increased risk for substance use disorders and nicotine dependence.AimsTo examine the effects of stimulant treatment on subsequent risk for substance use disorder and nicotine ...
Greven, C.U., Roeyers, H., Sergeant, J.A., Greven, CU, Rommelse, NNJ, Hartman, C.A., Oosterlaan, J, Buitelaar, JK, Oosterlaan, J., Hoekstra, P.J., Sergeant, Joseph A., Groenman, Annabeth P., Oosterlaan, Jaap, Groenman, AP, Rommelse, Nanda N. J., Franke, Barbara, Hoekstra, Pieter J., Franke, B., Rommelse, N., Roeyers, Herbert, Oades, Robert D., Faraone, Stephen V., Luman, Marjolein, Hartman, CA, Oades, RD, Faraone, SV, Groenman, A.P., Buitelaar, J.K., Hoekstra, PJ, Rommelse, N.N.J., Hartman, Catharina A., Luman, M., Greven, Corina U., Faraone, S.V., Luman, M, Oades, R.D., Luman, M.; id_orcid, Buitelaar, Jan K., Franke, B, Sergeant, JA   +39 more
core   +2 more sources

Stimulant use disorder and the likelihood of stroke: Analysis of a national database in the United States

Journal of Stroke and Cerebrovascular Diseases
Background: Stimulant use has been associated with an increased risk of stroke, though data on clinical characteristics and exact risk are limited. This retrospective case-control study examines stroke risk in individuals with stimulant use disorder ...
Akash Venkataramanan, MD, Divya Nayar, MD, Sama Almasri, MD, Thirumalaivasan Dhasakeerthi, MD, Sowmya Jayachandran, MD, Suryansh Bajaj, MD, Cheran Elangovan, MD   +6 more
doaj   +1 more source

Association of opioid and stimulant use disorder diagnoses with fatal and nonfatal overdose among people with a history of incarceration.

, 2022
Importance: Studies have suggested a rise in opioid- and stimulant-involved overdoses in recent years in North America. This risk may be acute for individuals who have had contact with the criminal justice system, who are particularly vulnerable to ...
Sedgemore, Kali-Olt, Gan, Wenqi, Scow, Marnie, Nicholls, Tonia, Xavier, Chloe, Slaunwhite, Amanda, Desai, Roshni, Palis, Heather, Greiner, Leigh   +8 more
core   +1 more source

Emerging neuromodulation treatments for opioid and stimulant use disorders

Frontiers in Human Neuroscience
Over the past decade, deaths attributable to opioid and stimulant use have risen dramatically. While the U.S. Food and Drug Administration (FDA) has approved three medications for opioid use disorder, there is currently no FDA-approved treatment for ...
Susanna D. Howard, Liming Qiu, Nathan Hager, Anna Rose Childress, Casey H. Halpern, Katherine W. Scangos, Katherine W. Scangos   +6 more
doaj   +1 more source

Bridging the Loneliness Gap: Depression, Connectivity, and Isolation in Pediatric Oncology Patients and Their Peers

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Loneliness is associated with adverse physical and mental health outcomes and remains understudied in children and adolescents undergoing cancer therapy. Pediatric oncology patients may be at increased risk due to medical isolation and disruption of social networks.
Charlotte N. Stahlfeld, Scott H. Maurer, Michelle D. Watkinson, John Nury, Elise Barberis, Molly C. Mack   +5 more
wiley   +1 more source

Accelerated Deep Transcranial Magnetic Stimulation for Stimulant Use Disorder

Brain Stimulation
Emma Bousseau, Maxime Richard, Véronique Desbeaumes Jodoin, Daniel Blumberger, Travis E. Baker, Elie Bou Assi, Simon Dubreuq, Paul Robert Juster, Didier Jutras Aswad, Paul Lespérance, Jean-Philippe Miron   +10 more
doaj   +2 more sources

Effects of Psychopathy on Neurocognitive Domains of Impulsivity in Abstinent Opiate and Stimulant Users

Frontiers in Psychiatry, 2021
Background: Psychopathy and substance use disorders (SUDs) are both characterized by neurocognitive impairments reflecting higher levels of impulsivity such as reward-driven decision-making and deficient inhibitory control.
Elena Psederska, Elena Psederska, Nicholas D. Thomson, Nicholas D. Thomson, Kiril Bozgunov, Dimitar Nedelchev, Georgi Vasilev, Jasmin Vassileva, Jasmin Vassileva   +8 more
doaj   +1 more source